查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2149722

2034年寵物預防保健市場預測－按產品類型、預防服務、寵物品種、通路、最終用戶和地區分類的全球分析

Preventative Pet Health Market Forecasts to 2034 - Global Analysis By Product Type, Preventive Service, Pet Type, Distribution Channel, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球寵物預防保健市場預計到 2026 年將達到 113 億美元，並在預測期內以 9.0% 的複合年成長率成長，到 2034 年達到 225 億美元。

寵物預防保健是指各種旨在預防疾病、在疾病發生前維護伴侶動物健康的產品和服務。該市場涵蓋的產品類型包括疫苗、寄生蟲預防產品、營養補充劑、牙齒預防產品、預防性美容和衛生產品以及其他預防性醫療產品。預防性服務包括定期獸醫檢查、疫苗接種、寄生蟲篩檢和預防、牙齒檢查和預防保健、診斷篩檢以及營養和健康諮詢。人們對預防保健意識的提高、寵物「人性化」的日益增強以及獸醫服務的擴展是推動市場成長的主要因素。

人們越來越意識到預防保健的益處和成本節約

寵物飼主日益認知到預防保健能夠改善寵物健康並降低長期成本，這是推動寵物預防保健市場發展的主要動力。定期體檢、接種疫苗和預防寄生蟲感染有助於預防疾病和早期發現。預防保健比治療晚期疾病更具成本效益。獸醫們正在透過飼主宣傳活動強調預防保健的重要性。隨著人們對預防保健益處的認知不斷提高，對預防性產品和服務的需求也不斷成長，從而支撐著市場的持續發展。

預防性醫療保健的成本和合規性方面面臨的挑戰。

定期獸醫檢查、疫苗接種和預防性藥物的費用，以及飼主依從性的挑戰，都是限制市場發展的主要阻礙因素。預防性護理需要持續投入。有些寵物飼主可能會出於費用或便利性的考慮而忽略預防性護理。此外，堅持定期護理計劃也可能存在困難。這些成本和依從性的障礙會阻礙市場成長。

擴大複合型和長效預防產品的供應

複方製劑和長效預防產品為市場拓展提供了巨大的機會。單次給藥即可發揮多種預防功效的產品提高了用藥便利性。長效製劑則減少了給藥次數。這些創新措施增強了病患的依從性和療效。隨著產品技術的進步，創新預防產品正不斷擴大市場佔有率。

與一般寵物護理產品的競爭

來自普通寵物護理產品和特異性營養補充劑的競爭對寵物預防保健市場構成重大威脅。有些寵物飼主可能會選擇使用普通產品而非特定的預防性藥物。預防性藥物和普通保健產品之間的重疊加劇了競爭。價格敏感性也可能成為消費者選擇的關鍵因素。這種競爭可能會影響市場成長。

新型冠狀病毒（COVID-19）的影響：

新冠疫情加速了寵物預防保健市場的發展，因為寵物飼主更加重視寵物的健康。對疫苗接種和預防性護理的需求增加。遠端醫療讓取得獸醫建議變得更加便捷。預防性產品的電商銷售額也隨之成長。即使在疫情結束後，人們對寵物健康的持續關注也支撐著市場的成長。

在預測期內，「疫苗」細分市場預計將佔據最大的市場佔有率。

預計在預測期內，疫苗細分市場將佔據最大的市場佔有率，這主要得益於疫苗接種在預防伴侶動物感染疾病發揮的關鍵作用。疫苗可以保護寵物免受狂犬病、犬瘟熱、犬細小病毒和其他嚴重的侵害。該細分市場受益於獸醫的廣泛推薦和監管要求。作為預防保健的基礎產品，疫苗在產品類型細分市場中佔據最大佔有率。

預計在預測期內，寄生蟲預防產品細分市場將呈現最高的複合年成長率。

在預測期內，寄生蟲預防產品細分市場預計將呈現最高的成長率，這主要得益於人們對寄生蟲疾病的認知不斷提高、產品選擇範圍擴大以及對便捷預防產品的需求日益成長。在許多地區，跳蚤、蜱蟲和心絲蟲的預防全年都至關重要。複方製劑和長效配方是該細分市場的主要優勢。隨著人們對寄生蟲的認知不斷提高，預計該產品類型將成為該細分市場中成長最快的品類。

市佔率最大的地區：

在整個預測期內，北美地區預計將保持最大的市場佔有率，這主要得益於其較高的寵物擁有率、大量的預防性醫療保健支出以及先進的獸醫基礎設施。美國憑藉其高疫苗接種率和廣泛的預防性醫療保健服務，正在推動該地區的成長。人們對預防益處的高度認知也促進了市場需求。完善的獸醫網路為市場准入提供了保障。高額的支出和對預防的高度重視確保了北美地區在市場上的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、印度、日本和東南亞寵物擁有量的成長、預防保健意識的提高以及獸醫服務的擴展。該地區寵物數量的快速成長正在產生巨大的需求。獸醫基礎設施的擴建也為市場成長提供了支持。隨著預防保健意識的增強，亞太地區將在全球寵物預防保健市場中實現最快的成長。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球寵物預防保健市場：依產品類型分類

  • 疫苗
  • 寄生蟲預防產品
    • 跳蚤和蜱蟲預防藥物
    • 預防犬心絲蟲的藥物
    • 體內寄生蟲控制產品
  • 營養補充品
  • 牙齒預防產品
  • 預防性儀容及衛生用品
  • 其他預防性醫療產品

第6章：全球寵物預防保健市場：依預防服務分類

  • 定期獸醫檢查
  • 疫苗接種服務
  • 寄生蟲篩檢和預防
  • 牙科檢查和預防保健
  • 診斷篩檢
  • 營養與健康諮詢

第7章 全球寵物預防保健市場：依寵物類型分類

  • 狗
  • 貓
  • 鳥
  • 其他伴侶動物

第8章：全球寵物預防保健市場：依通路分類

  • 獸醫醫院和獸醫診所
  • 寵物藥房
  • 寵物專賣店
  • 線上零售
  • 其他分銷管道

第9章 全球寵物預防保健市場：依最終用戶分類

  • 寵物飼主
  • 動物醫院
  • 寵物護理設施
  • 動物收容所和救援組織

第10章 全球寵物預防保健市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Ceva Sante Animale
  • Virbac SA
  • Vetoquinol SA
  • Dechra Pharmaceuticals PLC
  • Bayer AG
  • PetIQ, LLC
  • Central Garden & Pet Company
  • Beaphar BV
  • Norbrook Laboratories Limited
  • Phibro Animal Health Corporation
  • Indian Immunologicals Limited
Product Code: SMRC40181

According to Stratistics MRC, the Global Preventative Pet Health Market is accounted for $11.3 billion in 2026 and is expected to reach $22.5 billion by 2034 growing at a CAGR of 9.0% during the forecast period. Preventative pet health encompasses products and services designed to prevent disease and maintain the health of companion animals before illness occurs. The market encompasses product types including vaccines, parasite prevention products, nutritional supplements, dental preventive products, preventive grooming and hygiene products, and other preventive health products. Preventive services include routine veterinary examinations, vaccination services, parasite screening and prevention, dental screening and preventive care, diagnostic screening, and nutritional and wellness counseling. Growing awareness of preventive care, increasing pet humanization, and expanding veterinary services are key drivers of market expansion.

Market Dynamics:

Driver:

Growing awareness of preventive care benefits and cost savings

The increasing recognition among pet owners that preventive care improves health outcomes and reduces long-term costs is a primary driver for the preventative pet health market. Regular check-ups, vaccinations, and parasite prevention prevent disease and detect issues early. Preventive care is more cost-effective than treating advanced disease. Veterinarians emphasize preventive care in client education. As awareness of preventive benefits grows, demand for preventive products and services expands, supporting sustained market growth.

Restraint:

Cost of preventive care and compliance challenges

The costs associated with regular veterinary visits, vaccines, and preventive medications and challenges with owner compliance represent a major restraint for the market. Preventive care requires ongoing investment. Some pet owners may skip preventive care due to cost or convenience. Compliance with preventive schedules can be challenging. These cost and compliance barriers may constrain market growth.

Opportunity:

Expansion of combination and long-acting preventive products

The development of combination and long-acting preventive products presents significant opportunities for market expansion. Products that combine multiple preventives in one dose improve convenience. Long-acting formulations reduce dosing frequency. These innovations improve compliance and effectiveness. As product technology advances, innovative preventives capture growing market share.

Threat:

Competition from general pet care products

Competition from general pet care products and non-specific supplements poses significant threats to the preventative pet health market. Some pet owners may use general products rather than specific preventives. Overlap between preventive and general health products creates competition. Price sensitivity may drive choices. This competition may affect market growth.

Covid-19 Impact:

The COVID-19 pandemic accelerated preventative pet health market growth as pet owners prioritized health and wellness. Demand for vaccinations and preventive care increased. Telehealth expanded access to veterinary advice. E-commerce sales of preventive products grew. Post-pandemic, continued health focus has supported market growth.

The Vaccines segment is expected to be the largest during the forecast period

The Vaccines segment is expected to account for the largest market share during the forecast period, driven by the essential role of vaccination in preventing infectious diseases in companion animals. Vaccines protect against rabies, distemper, parvovirus, and other serious diseases. The segment benefits from widespread veterinary recommendation and regulatory requirements. As the foundational preventive care product, vaccines maintain the largest product type segment share.

The Parasite Prevention Products segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Parasite Prevention Products segment is predicted to witness the highest growth rate, fueled by increasing awareness of parasite-borne diseases, expanding product options, and growing demand for convenient preventives. Flea, tick, and heartworm prevention are essential year-round in many regions. The segment benefits from combination products and long-acting formulations. As parasite awareness grows, this product category delivers the fastest segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership, strong spending on preventive care, and advanced veterinary infrastructure. The United States leads regional growth with high vaccination rates and preventive care adoption. High awareness of preventive benefits drives demand. Well-established veterinary networks support market accessibility. With high spending and preventive focus, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing awareness of preventive care, and expanding veterinary services across China, India, Japan, and Southeast Asia. The region's rapidly growing pet population creates substantial demand. Increasing veterinary infrastructure supports market expansion. As preventive care awareness grows, Asia Pacific delivers the fastest preventative pet health market growth globally.

Key players in the market

Some of the key players in Preventative Pet Health Market include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Ceva Sante Animale, Virbac S.A., Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, PetIQ, LLC, Central Garden & Pet Company, Beaphar B.V., Norbrook Laboratories Limited, Phibro Animal Health Corporation, and Indian Immunologicals.

Key Developments:

In September 2026, Zoetis launched Lenivia (izenivetmab injection) in Great Britain, rolling out a long-acting monoclonal antibody targeting nerve growth factor (NGF) to provide up to three months of continuous osteoarthritis pain alleviation in dogs.

In June 2026, Ceva Sante Animale convened global health summits focusing on herd and companion preventative immunization to minimize antibiotic dependency and mitigate zoonotic disease exposure.

In March 2025, Virbac launched an updated dental care program for dogs and cats, pairing enzymatic toothpastes and chews with preventative oral health screening protocols.

Product Types Covered:

  • Vaccines
  • Parasite Prevention Products
  • Nutritional Supplements
  • Dental Preventive Products
  • Preventive Grooming and Hygiene Products
  • Other Preventive Health Products

Preventive Services Covered:

  • Routine Veterinary Examinations
  • Vaccination Services
  • Parasite Screening and Prevention
  • Dental Screening and Preventive Care
  • Diagnostic Screening
  • Nutritional and Wellness Counseling

Pet Types Covered:

  • Dogs
  • Cats
  • Birds
  • Other Companion Animals

Distribution Channels Covered:

  • Veterinary Clinics and Hospitals
  • Pet Pharmacies
  • Pet Specialty Stores
  • Online Retail
  • Other Distribution Channels

End Users Covered:

  • Pet Owners
  • Veterinary Practices
  • Pet Care Facilities
  • Animal Shelters and Rescue Organizations

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Preventative Pet Health Market, By Product Type

  • 5.1 Vaccines
  • 5.2 Parasite Prevention Products
    • 5.2.1 Flea and Tick Preventives
    • 5.2.2 Heartworm Preventives
    • 5.2.3 Internal Parasite Control Products
  • 5.3 Nutritional Supplements
  • 5.4 Dental Preventive Products
  • 5.5 Preventive Grooming and Hygiene Products
  • 5.6 Other Preventive Health Products

6 Global Preventative Pet Health Market, By Preventive Service

  • 6.1 Routine Veterinary Examinations
  • 6.2 Vaccination Services
  • 6.3 Parasite Screening and Prevention
  • 6.4 Dental Screening and Preventive Care
  • 6.5 Diagnostic Screening
  • 6.6 Nutritional and Wellness Counseling

7 Global Preventative Pet Health Market, By Pet Type

  • 7.1 Dogs
  • 7.2 Cats
  • 7.3 Birds
  • 7.4 Other Companion Animals

8 Global Preventative Pet Health Market, By Distribution Channel

  • 8.1 Veterinary Clinics and Hospitals
  • 8.2 Pet Pharmacies
  • 8.3 Pet Specialty Stores
  • 8.4 Online Retail
  • 8.5 Other Distribution Channels

9 Global Preventative Pet Health Market, By End User

  • 9.1 Pet Owners
  • 9.2 Veterinary Practices
  • 9.3 Pet Care Facilities
  • 9.4 Animal Shelters and Rescue Organizations

10 Global Preventative Pet Health Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Zoetis Inc.
  • 13.2 Elanco Animal Health Incorporated
  • 13.3 Boehringer Ingelheim International GmbH
  • 13.4 Merck & Co., Inc.
  • 13.5 Ceva Sante Animale
  • 13.6 Virbac S.A.
  • 13.7 Vetoquinol S.A.
  • 13.8 Dechra Pharmaceuticals PLC
  • 13.9 Bayer AG
  • 13.10 PetIQ, LLC
  • 13.11 Central Garden & Pet Company
  • 13.12 Beaphar B.V.
  • 13.13 Norbrook Laboratories Limited
  • 13.14 Phibro Animal Health Corporation
  • 13.15 Indian Immunologicals Limited

List of Tables

  • Table 1 Global Preventative Pet Health Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Preventative Pet Health Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Preventative Pet Health Market Outlook, By Vaccines (2023-2034) ($MN)
  • Table 4 Global Preventative Pet Health Market Outlook, By Parasite Prevention Products (2023-2034) ($MN)
  • Table 5 Global Preventative Pet Health Market Outlook, By Flea and Tick Preventives (2023-2034) ($MN)
  • Table 6 Global Preventative Pet Health Market Outlook, By Heartworm Preventives (2023-2034) ($MN)
  • Table 7 Global Preventative Pet Health Market Outlook, By Internal Parasite Control Products (2023-2034) ($MN)
  • Table 8 Global Preventative Pet Health Market Outlook, By Nutritional Supplements (2023-2034) ($MN)
  • Table 9 Global Preventative Pet Health Market Outlook, By Dental Preventive Products (2023-2034) ($MN)
  • Table 10 Global Preventative Pet Health Market Outlook, By Preventive Grooming and Hygiene Products (2023-2034) ($MN)
  • Table 11 Global Preventative Pet Health Market Outlook, By Other Preventive Health Products (2023-2034) ($MN)
  • Table 12 Global Preventative Pet Health Market Outlook, By Preventive Service (2023-2034) ($MN)
  • Table 13 Global Preventative Pet Health Market Outlook, By Routine Veterinary Examinations (2023-2034) ($MN)
  • Table 14 Global Preventative Pet Health Market Outlook, By Vaccination Services (2023-2034) ($MN)
  • Table 15 Global Preventative Pet Health Market Outlook, By Parasite Screening and Prevention (2023-2034) ($MN)
  • Table 16 Global Preventative Pet Health Market Outlook, By Dental Screening and Preventive Care (2023-2034) ($MN)
  • Table 17 Global Preventative Pet Health Market Outlook, By Diagnostic Screening (2023-2034) ($MN)
  • Table 18 Global Preventative Pet Health Market Outlook, By Nutritional and Wellness Counseling (2023-2034) ($MN)
  • Table 19 Global Preventative Pet Health Market Outlook, By Pet Type (2023-2034) ($MN)
  • Table 20 Global Preventative Pet Health Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 21 Global Preventative Pet Health Market Outlook, By Cats (2023-2034) ($MN)
  • Table 22 Global Preventative Pet Health Market Outlook, By Birds (2023-2034) ($MN)
  • Table 23 Global Preventative Pet Health Market Outlook, By Other Companion Animals (2023-2034) ($MN)
  • Table 24 Global Preventative Pet Health Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 25 Global Preventative Pet Health Market Outlook, By Veterinary Clinics and Hospitals (2023-2034) ($MN)
  • Table 26 Global Preventative Pet Health Market Outlook, By Pet Pharmacies (2023-2034) ($MN)
  • Table 27 Global Preventative Pet Health Market Outlook, By Pet Specialty Stores (2023-2034) ($MN)
  • Table 28 Global Preventative Pet Health Market Outlook, By Online Retail (2023-2034) ($MN)
  • Table 29 Global Preventative Pet Health Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 30 Global Preventative Pet Health Market Outlook, By End User (2023-2034) ($MN)
  • Table 31 Global Preventative Pet Health Market Outlook, By Pet Owners (2023-2034) ($MN)
  • Table 32 Global Preventative Pet Health Market Outlook, By Veterinary Practices (2023-2034) ($MN)
  • Table 33 Global Preventative Pet Health Market Outlook, By Pet Care Facilities (2023-2034) ($MN)
  • Table 34 Global Preventative Pet Health Market Outlook, By Animal Shelters and Rescue Organizations (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW)

Regions are also represented in the same manner as above.